Actemra 160mg, a treatment known scientifically as tocilizumab, is a a potent pharmaceutical agent primarily employed for the control of rheumatoid arthritis. This remarkable substance acts by interfering with the activity of interleukin-6 (IL-6), a signaling protein essential in the inflammatory process. Additionally, Actemra exhibits promise in